LGM
CGEM icon

Logos Global Management’s Cullinan Oncology CGEM Stock Holding History

Logos Global Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700,000
Closed -$11.9M – 60
2024
Q1 		$11.9M Buy
+700,000
New +$10.8M 0.97% 31
2022
Q2 		– Sell
-200,000
Closed -$2.09M – 36
2022
Q1 		$2.09M Sell
200,000
-88,458
-31% -$1.2M 0.27% 32
2021
Q4 		$4.45M Hold
288,458
– – 0.46% 45
2021
Q3 		$6.51M Hold
288,458
– – 0.47% 40
2021
Q2 		$7.43M Sell
288,458
-125,000
-30% -$3.84M 0.62% 40
2021
Q1 		$17.2M Buy
+413,458
New +$16.8M 1.68% 15

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Logos Global Management's CGEM Position: Q2 2024 in Review

Logos Global Management sold out of Cullinan Oncology (CGEM) in Q2 2024, closing a stake of 700,000 shares — an estimated $11.9M sold.

Logos Global Management first reported a position in CGEM in Q1 2021 and held it in 6 quarters. The position peaked at $17.2M in Q1 2021. 135 funds tracked by Wall St. Rank hold CGEM as of Q2 2024.

  • Logos Global Management reported no remaining Cullinan Oncology position as of Q2 2024 after selling out during the quarter.
  • Logos Global Management sold 700,000 Cullinan Oncology shares in Q2 2024, an estimated $11.9M.
  • Logos Global Management first reported a position in Cullinan Oncology in Q1 2021 and held it in 6 quarters.
  • Logos Global Management's Cullinan Oncology position peaked at $17.2M in Q1 2021.
  • 135 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2024.

Based on Logos Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.